Screener
CorMedix CRMD Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $25.99M+31.1% | $38.6M+87.0% | $56.45M— | $52.58M+1,993% | $19.83M+240% | ||
| $0.29+3.6% | $0.43+43.3% | $0.07— | $1.26+2,620% | $0.28+212% | ||
| $53.45M+171% | $74.2M+266% | $69.56M— | $55.11M+1,817% | $19.71M+229% | ||
| $42.91M+120% | $63.66M+216% | $59.13M— | $51.35M+1,662% | $19.54M+228% |
FAQ
- What is CorMedix's revenue?
- CorMedix (CRMD) generated $462.2M in revenue over the trailing twelve months, up 280.5% year over year.
- Is CorMedix profitable?
- CorMedix reported $173.6M in net income over the trailing twelve months, a 37.6% net margin.
- What are CorMedix's profit margins?
- Gross margin is 90.2% and operating margin is 47.0%, with a 37.6% net margin.
- What is CorMedix's earnings per share?
- CorMedix's diluted EPS over the trailing twelve months is $2.05.
- Where does CorMedix's income statement data come from?
- Every line is extracted from CorMedix's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
